Influence of the human T-lymphotropic virus/lymphadenopathy-associated virus on functions of human lymphocytes: evidence for immunosuppressive effects and polyclonal B-cell activation by banded viral preparations.
about
Human immunodeficiency virus proteins induce the inhibitory cAMP/protein kinase A pathway in normal lymphocytesPathogenesis of human immunodeficiency virus infectionRole of molecular mimicry of hepatitis C virus protein with platelet GPIIIa in hepatitis C-related immunologic thrombocytopeniaCytopathic effect of human immunodeficiency virus in T4 cells is linked to the last stage of virus infection.Polyclonal B-cell activation reveals antibodies against human immunodeficiency virus type 1 (HIV-1) in HIV-1-seronegative individualsPresence of antibodies to a putatively immunosuppressive part of human immunodeficiency virus (HIV) envelope glycoprotein gp41 is strongly associated with health among HIV-positive subjects.Immunoregulatory activities of human immunodeficiency virus (HIV) proteins: effect of HIV recombinant and synthetic peptides on immunoglobulin synthesis and proliferative responses by normal lymphocytes.Serum IgD elevation is an early marker of B cell activation during infection with the human immunodeficiency viruses.Theoretical implications of cellular immune reactions against helper lymphocytes infected by an immune system retrovirus.Recombinant hydrophilic region of murine retroviral protein p15E inhibits stimulated T-lymphocyte proliferation.Noninfectious X4 but not R5 human immunodeficiency virus type 1 virions inhibit humoral immune responses in human lymphoid tissue ex vivoSuppressive effect on polyclonal B-cell activation of a synthetic peptide homologous to a transmembrane component of oncogenic retroviruses.Prematurity, hypogammaglobulinemia, and neuropathology with human immunodeficiency virus (HIV) infection.Specific cellular immune response and neutralizing antibodies in goats immunized with native or recombinant envelope proteins derived from human T-lymphotropic virus type IIIB and in human immunodeficiency virus-infected men.Identification of NAD+ synthetase from Streptococcus sobrinus as a B-cell-stimulatory proteinThe Vancouver Lymphadenopathy-AIDS Study: 5. Antecedent behavioural, clinical and laboratory findings in patients with AIDS and HIV-seropositive controls.The Vancouver Lymphadenopathy-AIDS Study: 7. Clinical and laboratory features of 87 cases of primary HIV infection.PolyI.polyC12U-mediated inhibition of loss of alloantigen responsiveness viral replication in human CD4+ T cell clones exposed to human immunodeficiency virus in vitro.Human immunodeficiency virus infection induces both polyclonal and virus-specific B cell activation.Clonal patterns in the human immune response to HIV-1 infection.Human immunodeficiency virus Tat induces functional unresponsiveness in T cells.HTLV-III expression in infected lymph nodes and relevance to pathogenesis of lymphadenopathySuppression of virus-specific antibody production by CD8+ class I-restricted antiviral cytotoxic T cells in vivo.Human immunodeficiency virus type 1 envelope glycoproteins gp120 and gp160 induce interleukin-6 production in CD4+ T-cell clonesInhibition of lymphoproliferation by a synthetic peptide with sequence identity to gp41 of human immunodeficiency virus type 1Protective effect of a T-cell-dependent immunosuppressive, B-cell-mitogenic protein (F3'EP-Si, or P90) produced by Streptococcus intermedius.Stimulatory and inhibitory influences of human immunodeficiency virus on normal B lymphocytes.Current issues in developing a strategy for dealing with the acquired immunodeficiency syndrome.Impaired immunity in AIDS. The mechanisms responsible and their potential reversal by antiviral therapy.Immunology of HIV infection.Reproductive immunology of human immunodeficiency virus (HIV-1) infection.Acquired immune deficiency syndrome in children.Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infections.Replication of an acutely lethal simian immunodeficiency virus activates and induces proliferation of lymphocytes.Replication of the human immunodeficiency virus 1 and impaired differentiation of T cells after in vitro infection of bone marrow immature T cells.TGF beta and HIV infection.B cell superantigens in HIV-1 infection.CD4 receptor binding peptides that block HIV infectivity cause human monocyte chemotaxis. Relationship to vasoactive intestinal polypeptide.Circulating Plasmablasts from Chronically Human Immunodeficiency Virus-Infected Individuals Predominantly Produce Polyreactive/Autoreactive Antibodies.Immune dysfunction and the pathogenesis of AIDS-associated non-Hodgkin's lymphoma.
P2860
Q24562117-185CCA86-A13F-4C58-8738-9A99E3D4EC6FQ24634681-8E0EF9B8-CB59-4DDE-B7E8-F649F3941D20Q27488342-875DC2D8-347E-4CE5-94BD-EB1BB01A8CCBQ33575253-805FAC9C-D231-47B6-899F-3BA4B5BEF0E9Q33595408-49335DB4-1579-45E9-9FA1-75E30D6FD04CQ33632833-DF6A53FA-00CB-4983-A146-A756E619E42CQ33645169-B066ACC9-A450-4020-BFD4-A384B1F2FD78Q34181086-6634192C-A8A8-45BA-B8BE-92DBDB4FE424Q34355015-A700E7EA-6067-4E84-8A3A-1C21428EC62FQ34355308-716975CA-7CB9-4C8A-9E3A-0F6CCDFC4ADCQ34437067-7A772E6B-5C25-4FF6-8153-B7DE900A4FCCQ34586279-0DB3FB03-82C0-4E94-B75D-89168B7382F7Q34628378-C759868E-7A34-4563-BC77-FC454464BF01Q34640420-1A7CF539-E4B9-43BF-8BD2-F5C03D49A8D0Q34674539-ABD7FDCB-6883-4318-B6BB-FC3DC7DCA1A4Q34729394-AD8571E4-18ED-4127-9219-E107B244DDCDQ34733893-41B4F683-89EA-4C5D-BD93-F4A3C4EC522BQ35583044-81B5B237-2B31-41B6-B2F9-21A6233E6EB3Q35597873-1C7E6554-2F2B-4392-97C5-12EE188C175AQ35658414-5886E04F-5D5F-4A96-B024-59D23A1A9C09Q35830177-2276454C-BAEC-4D9D-9CE1-EE28FD508EABQ35836582-A3FA1574-B25F-4F4F-A5B4-DD1D1411F870Q36698144-0E70D9D6-7633-4BFC-AD51-3A4DFD25452FQ36822254-DCAAF7E4-F1F3-4F3C-A2D5-097287B5C795Q36829695-CAE9EAB4-D676-4437-B978-E113BA691489Q36950366-ABB0886D-B8F8-4FAC-9992-65BC9C528EAFQ37409831-6AD21020-B2CE-45AF-A7DA-37BBC78DB508Q37410532-07EFDF56-3727-4E73-A002-4852FF9B1C3CQ37612103-7AFF6058-8B86-43B5-8D89-C5F6B7E5EAB1Q37615905-C1558B57-C235-4D03-A0A9-19FFA6B06297Q38025573-FD9B89EC-B255-497F-822B-B241C3FB3608Q39562992-3CCE4DEF-A56C-45EF-998E-1A040FE60982Q39574498-F63D4B5A-55BB-4A27-BA90-25D37BAA4FF6Q40106752-DCE4DAFF-8EBB-4DC1-8DA4-ED05F6732555Q40378772-353943A6-0973-4806-9919-B1B58EDAC9A5Q40489692-3DFDF50B-C664-43FF-9CBC-BF27F8F6FD12Q41501227-9534527B-5EAD-40DD-BF2E-B813DE8510C2Q42125831-A71FBAB7-EEAC-4D72-83ED-F68D3C4EFD93Q47095100-0209577B-C7DE-459C-AE57-9F8C4E8EA73DQ47707811-00DCC622-FF8C-4BE0-807C-11F95F6E0388
P2860
Influence of the human T-lymphotropic virus/lymphadenopathy-associated virus on functions of human lymphocytes: evidence for immunosuppressive effects and polyclonal B-cell activation by banded viral preparations.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 1985
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Influence of the human T-lymph ...... by banded viral preparations.
@en
Influence of the human T-lymph ...... by banded viral preparations.
@nl
type
label
Influence of the human T-lymph ...... by banded viral preparations.
@en
Influence of the human T-lymph ...... by banded viral preparations.
@nl
prefLabel
Influence of the human T-lymph ...... by banded viral preparations.
@en
Influence of the human T-lymph ...... by banded viral preparations.
@nl
P2093
P2860
P356
P1476
Influence of the human T-lymph ...... by banded viral preparations.
@en
P2093
P2860
P304
P356
10.1073/PNAS.82.23.8198
P407
P50
P577
1985-12-01T00:00:00Z